Personal tools
You are here: Home Conferences Healthcare The Chronic Disease Management Summit Agenda

Agenda

 
DAY ONE Thursday 4th December 2008
8.30
Registration and coffee
CDM CHALLENGES AND OPPORTUNITIES
9.00
Chairmans opening remarks
Associate Professor Gawaine Powell-Davies, Chief Executive Officer, UNSW Research Center for Primary Health Care & Equity
9.10
KEYNOTE INTERNATIONAL ADDRESS | Chronic Disease Management in a globalised world
  • Trends in chronic disease growth and expenditure
9.50
KEYNOTE ADDRESS | Chronic care costs in Australia: new insights on the relationships of adverse events, co morbidity and preventable hospitalisation that should shape future payment reforms
  • Chronic conditions, risk factors and care gaps: what we know
  • Data limitations, data linkage and privacy: what we do not know
  • Four linked policy concerns: adverse events, preventable admissions, co morbidity and efficient provider payment systems
  • Some really expensive chronic conditions: new data on total direct costs of their care and likely growth patterns
  • Alternative payment systems that might improve patient satisfaction, provider satisfaction and efficiency
  • Reassessing the four Ps: primary care, prevention, population health management and the patient role

Dr. Paul Gross, Health Economist, Director, Institute of Health Economics & Technology Assessment
10.30
Refreshments and networking break
11.00
The business case for investing in workforce CDM
  • Cost effective solutions for employers
  • Scope for potential improvements in productivity
  • Measuring absenteeism and presenteeism

Dr. John Lang, President HAPIA, Managing Director, Good Health Solutions
11.40
Managing chronic health conditions
  • Integrating health coaching into organisational systems

Janette Gale, Director, Health Coaching Australia
12.10
Lunch
TOWARDS NATIONAL COORDINATION OF CDM INITIATIVES
1.10
CDM EXPERT PANEL SESSION | Towards better coordination of CDM initiatives
  • Managing a multi-provider environment
  • The role for Super Clinics in CDM
  • The National Primary Health Care Partnership and CDM
  • Towards centralisation and coordination of CDM providers: addressing conflicting drivers
  • Taking a unified approach: forming partnerships and alliances
  • Facilitating collaborative involvement

Moderator:
Richard Royle, Vice President APHA and Chief Executive Officer, UnitingCare Health
Dr. Stan Goldstein, Senior Medical Advisor, BUPA Australia Group
Dr. Gary Deed, President, Diabetes Australia
Liesel Wett, Acting Chief Executive Officer, Australian General Practice Network
2.20
CASE STUDY | The Team Care Coordination program in Queensland
  • Outcomes so far

Abbe Anderson, Chief Executive Officer, GPpartners
2.50
Refreshments and networking break
FUNDING CDM PROGRAMS
3.10
PANEL DISCUSSION | In search of an efficient CDM financing model
  • Allowing the funding model to engage seamlessly across the continuum of care
  • Measuring economic outcomes beyond healthcare: aligning reimbursement models and reviewing government funding programs to improve outcomes access, effectiveness - and efficiency
  • Assessing the possible impact of economic incentives and self management on quality and cost of CDM
  • Implications for Medicare and Private Health Insurance

Professor Stephen Leeder, Director, Australian Health Policy Institute
Dr. Andrew Boyden, National Director-Clinical Issues, National Heart Foundation
Liesel Wett, Acting Chief Executive Officer, Australian General Practice Network
Mary Foley, National Health Practice Leader, PricewaterhouseCoopers
MEASURING THE VALUE OF CDM PROGRAMS
4.10
CASE STUDY | Measurement and evaluation of Chronic Disease Management Progra
  • Designing and implementing an evaluation approach for chronic disease programs
  • Critically analysing the validity of outcomes reports
  • Practical guidelines to measuring CDM ROIs
  • Accurately measuring the economic value of CDM investments

Julie Andrews, Group Manager Health Services, Medibank Private
4.40
Closing remarks from the Chair
 
DAY TWO Friday 5th December 2008
8.45
Registration and coffee
9.00
Welcome from the Chair
DRIVING INNOVATION IN CDM
9.10
Embracing opportunities for private providers
  • Improving capacity and operations to provide quality care
  • Meeting financial and performance targets
  • Looking ahead as to how the industry will meet the CDM challenge

Mark Fitzgibbon, Chief Executive Officer, NIB Health Funds
9.45
Health Fund's Perspective on CDM
Terry Smith, Chief Executive Officer, HCF of Australia
10.20
Refreshments and networking break
10.50
The future of CDM in Australia
  • Challenges in todays market
  • Market opportunities for service providers
  • International market opportunities

Dr. Andrew Wilson, Co-President, McKesson Asia-Pacific
11.30
Achieving solutions that deliver cost effective outcomes
  • Evaluating outcomes: what has been done and what can be achieved
  • Case studies from Australia and overseas

Louise Stewart, Managing Director, Revive Group
12.10
Lunch
PHARMACEUTICALS
1.20
Implementing strategies to increase compliance
  • Examining the progress of existing Quality Use of Medicines Programs
  • Successfully incorporating compliance drivers into CDM
  • Involving the pharmacists in monitoring compliance
  • Impact on healthcare costs

Professor Carol Armour, Acting Pro-Vice Chancellor (Research), University of Sydney
LEVERING TECHNOLOGY TO INCREASE THE IMPACT OF CDM
2.00
IT infrastructures, electronic health records and CDM
  • Towards better sharing arrangements and standards
  • Using IT to integrate care for chronic conditions and improve clinical outcomes
  • Challenges that need to be addressed

Roger Glenny, General Manager, National e-Health Transition Authority
2.30
Microsofts entry in the online health care market
  • Extending traditional healthcare services to the home setting
  • Capitalising on opportunities using the latest in web communication technologies
  • The micro and macro business case
  • Operating in different markets
  • Potential for Chronic Disease Management programs

Dr David Dembo, Leader, Health and Human Services, Microsoft Australia
3.00
Refreshments and networking break
3.20
Using technology to deliver CDM programs across large populations including regional and remote areas
  • Experiences so far with remote monitoring
  • Training patients to become independent
  • Clinical outcomes

Professor Branko Celler, Director, Biomedical Systems Laboratory and Laboratory for Health Telemedics, University of New South Wales
3.50
CASE STUDY | The implementation of an Intelligent Disease Management Service
  • Opportunities for telecare monitoring with decision support for chronic disease
  • E-Health pilot for Chronic Disease Management
  • Using emerging mobile technologies and remote monitors

Professor Michael Georgeff, Director e-Health Research, Monash University, Chief Executive Officer, Precedence Healthcare
4.30
Closing remarks from the Chair
End of the conference
Document Actions